Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 319

1.

Statin therapy as prevention against development of acute respiratory distress syndrome: an observational study.

Bajwa EK, Malhotra CK, Thompson BT, Christiani DC, Gong MN.

Crit Care Med. 2012 May;40(5):1470-7. doi: 10.1097/CCM.0b013e3182416d7a.

2.

Impact of statin therapy on mortality in patients with sepsis-associated acute respiratory distress syndrome (ARDS) depends on ARDS severity: a prospective observational cohort study.

Mansur A, Steinau M, Popov AF, Ghadimi M, Beissbarth T, Bauer M, Hinz J.

BMC Med. 2015 Jun 1;13:128. doi: 10.1186/s12916-015-0368-6.

3.

Cytomegalovirus seroprevalence as a risk factor for poor outcome in acute respiratory distress syndrome*.

Ong DS, Klein Klouwenberg PM, Verduyn Lunel FM, Spitoni C, Frencken JF, Dekker HA, Schultz MJ, Bonten MJ, Cremer OL.

Crit Care Med. 2015 Feb;43(2):394-400. doi: 10.1097/CCM.0000000000000712.

PMID:
25377020
4.

Prehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury/acute respiratory distress syndrome.

O'Neal HR Jr, Koyama T, Koehler EA, Siew E, Curtis BR, Fremont RD, May AK, Bernard GR, Ware LB.

Crit Care Med. 2011 Jun;39(6):1343-50. doi: 10.1097/CCM.0b013e3182120992.

5.

Association between statin therapy and outcomes in critically ill patients: a nested cohort study.

Al Harbi SA, Tamim HM, Arabi YM.

BMC Clin Pharmacol. 2011 Aug 6;11:12. doi: 10.1186/1472-6904-11-12.

6.

Statin use and risk of delirium in the critically ill.

Page VJ, Davis D, Zhao XB, Norton S, Casarin A, Brown T, Ely EW, McAuley DF.

Am J Respir Crit Care Med. 2014 Mar 15;189(6):666-73. doi: 10.1164/rccm.201306-1150OC.

7.

Statins and outcomes in patients with bloodstream infection: a propensity-matched analysis.

Leung S, Pokharel R, Gong MN.

Crit Care Med. 2012 Apr;40(4):1064-71. doi: 10.1097/CCM.0b013e31823bc9e7.

8.

In the critically ill patient, diabetes predicts mortality independent of statin therapy but is not associated with acute lung injury: a cohort study.

Koh GC, Vlaar AP, Hofstra JJ, de Jong HK, van Nierop S, Peacock SJ, Wiersinga WJ, Schultz MJ, Juffermans NP.

Crit Care Med. 2012 Jun;40(6):1835-43. doi: 10.1097/CCM.0b013e31824e1696.

9.

Statins do not prevent acute organ failure in ventilated ICU patients: single-centre retrospective cohort study.

Terblanche MJ, Pinto R, Whiteley C, Brett S, Beale R, Adhikari NK.

Crit Care. 2011;15(1):R74. doi: 10.1186/cc10063.

10.

Outcomes of acute respiratory distress syndrome (ARDS) in elderly patients.

Eachempati SR, Hydo LJ, Shou J, Barie PS.

J Trauma. 2007 Aug;63(2):344-50.

PMID:
17693834
11.

Prognostic value of plasma N-terminal probrain natriuretic peptide levels in the acute respiratory distress syndrome.

Bajwa EK, Januzzi JL, Gong MN, Thompson BT, Christiani DC.

Crit Care Med. 2008 Aug;36(8):2322-7. doi: 10.1097/CCM.0b013e318181040d.

12.

Prehospital aspirin use is associated with reduced risk of acute respiratory distress syndrome in critically ill patients: a propensity-adjusted analysis.

Chen W, Janz DR, Bastarache JA, May AK, O'Neal HR Jr, Bernard GR, Ware LB.

Crit Care Med. 2015 Apr;43(4):801-7. doi: 10.1097/CCM.0000000000000789.

13.
14.

Plasma adiponectin and mortality in critically ill subjects with acute respiratory failure.

Walkey AJ, Rice TW, Konter J, Ouchi N, Shibata R, Walsh K, deBoisblanc BP, Summer R.

Crit Care Med. 2010 Dec;38(12):2329-34. doi: 10.1097/CCM.0b013e3181fa0561.

15.

Low stretch ventilation strategy in acute respiratory distress syndrome: eight years of clinical experience in a single center.

Page B, Vieillard-Baron A, Beauchet A, Aegerter P, Prin S, Jardin F.

Crit Care Med. 2003 Mar;31(3):765-9.

PMID:
12626981
16.

Body mass index and acute kidney injury in the acute respiratory distress syndrome.

Soto GJ, Frank AJ, Christiani DC, Gong MN.

Crit Care Med. 2012 Sep;40(9):2601-8.

17.

The association between statin therapy during intensive care unit stay and the incidence of venous thromboembolism: a propensity score-adjusted analysis.

Al Harbi SA, Khedr M, Al-Dorzi HM, Tlayjeh HM, Rishu AH, Arabi YM.

BMC Pharmacol Toxicol. 2013 Nov 11;14:57. doi: 10.1186/2050-6511-14-57.

18.

Acute lung injury in critical neurological illness.

Hoesch RE, Lin E, Young M, Gottesman RF, Altaweel L, Nyquist PA, Stevens RD.

Crit Care Med. 2012 Feb;40(2):587-93. doi: 10.1097/CCM.0b013e3182329617.

PMID:
21946655
19.

Reduction in mortality associated with statin therapy in patients with severe sepsis.

Dobesh PP, Klepser DG, McGuire TR, Morgan CW, Olsen KM.

Pharmacotherapy. 2009 Jun;29(6):621-30. doi: 10.1592/phco.29.6.621.

PMID:
19476415
20.

Incidence of Sepsis and Mortality With Prior Exposure of HMG-COA Reductase Inhibitors in a Surgical Intensive Care Population.

Schurr JW, Wu W, Smith-Hannah A, Smith CJ, Barrera R.

Shock. 2016 Jan;45(1):10-5. doi: 10.1097/SHK.0000000000000484.

PMID:
26674450
Items per page

Supplemental Content

Support Center